SC83288 is an antimalarial candidate in preclinical development. Here the authors show that SC83288 kills malaria parasites by blocking DNA replication, while resistance arises through PfATP6-mediated sequestration of the compound into the endoplasmic reticulum.
- Cecilia P. Sanchez
- Maëlle Duffey
- Michael Lanzer
